Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

NASA Awards National Stem Cell Foundation $3.1M to Continue Studying Effects of Microgravity on Brain Cells


News provided by

National Stem Cell Foundation

Mar 27, 2025, 08:30 ET

Share this article

Share toX

Share this article

Share toX

Kentucky Senate President Robert Stivers and Paula Grisanti, National Stem Cell Foundation CEO, announce a multi-million award from NASA for pioneering space-based research
Kentucky Senate President Robert Stivers and Paula Grisanti, National Stem Cell Foundation CEO, announce a multi-million award from NASA for pioneering space-based research

Funding will Accelerate Commercialization of Flight-proven Research Models that Could Drive New Cures for Neurodegenerative Diseases Affecting Millions Worldwide

FRANKFORT, Ky., March 27, 2025 /PRNewswire-PRWeb/ -- The National Stem Cell Foundation (NSCF), a leading funder of space-based research on brain cells to fight neurodegenerative conditions like Parkinson's, progressive MS, and Alzheimer's, announced today a $3.1 million award from NASA to continue its breakthrough studies on brain cell behavior in microgravity.

The announcement was made during a press conference in Kentucky's capital hosted by Kentucky Senate President Robert Stivers and senior officials from NSCF. The team's patent-pending method for the long-duration in-space culturing of organoids (tiny 3D replicas of an organ that mimic cell behavior) has already been widely adopted by the space community.

"We're looking for new treatments and curative therapies for Parkinson's, MS, Alzheimer's, and other neurodegenerative diseases leveraging the accelerated environment of microgravity," says Dr. Paula Grisanti, CEO of NSCF.

Post this

The NASA award will fund additional ground research and another three missions to the International Space Station (ISS) through 2027. The Commonwealth of Kentucky, with a growing presence in the rapidly expanding space economy, is providing a 10% match for the NASA award valued at $300,000.

"This matching NASA grant shows Kentucky's commitment to investing not just in this generation, but in the ones to come," said Senate President Robert Stivers, R-Manchester. "Our state faces serious health challenges, and investing $300,000 now reinforces our dedication to improving health outcomes, enhancing quality of life, and increasing longevity. By helping people live longer, healthier, and more productive lives, we are strengthening families, communities, and the future of the Commonwealth."

Funds were allocated in Kentucky's 2024 General Assembly's passage of Senate Bill 91.

NSCF has conducted six missions on the ISS since 2019, sending 3D organoid models of the human brain to the orbiting laboratory. Organoids for the first six flights have been made from the cells of people with Parkinson's disease and primary progressive MS. The next flights will also include organoids made from the cells of people with Alzheimer's. Findings from the research have been recently published in Stem Cells Translational Medicine.

In the last round of highly competitive In Space Production Application (InSPA) awards, NSCF was NASA's first and top priority selection for alignment with NASA strategic goals of developing applications that will significantly improve the quality of life for people on Earth, strengthen U.S. technological leadership, and create high-quality jobs. These missions continue our commercial development partnership with Axiom Space, the leading provider of human spaceflight services, operating end-to-end missions to the ISS while developing its successor, Axiom Station.

Modeling Diseases in Space

The ability to observe cell interactions in a way not possible on Earth is opening the door to new cell, drug, and gene therapies for neurodegenerative diseases that affect thousands of Kentuckians and tens of millions worldwide.

"We're looking for new treatments and curative therapies for Parkinson's, MS, Alzheimer's, and other neurodegenerative diseases leveraging the accelerated environment of microgravity," says Dr. Paula Grisanti, CEO of NSCF. "Solving the puzzle of these diseases will have a knock-on effect for these and other neurodegenerative diseases that include ALS and a number of rare childhood disorders.

The WHO estimates that over 65 million people worldwide suffer from neurodegenerative diseases, including various forms of dementia (Alzheimer's being the most common form), Parkinson's disease and MS. The cost of care for PD, MS, and AD in the U.S. is expected to reach well over $2 trillion in the next two decades and increase steadily as the population ages. According to a report from Alzheimer's Disease International, the number of people living with dementia alone is expected to double every 20 years, reaching 78 million in 2030 and 139 million in 2050.

"When we began this mission, we had no idea what was going to happen," recalls Dr. Jeanne Loring, NSCF's Senior Scientific Advisor and founder of the Center of Regenerative Medicine at Scripps Research. A key learning was that microgravity accelerated cell development, providing insights to help identify and develop therapeutic interventions more rapidly.

NSCF researchers can make brain organoids from anyone, including people who have mutations for these diseases. The ultimate goal is to provide flight-proven, validated models of these diseases to industry, academic institutions, and foundations for the accelerated development of new diagnostics and novel treatments for neurodegenerative diseases. These models can also help NASA develop countermeasures for the effects of space flight on astronauts participating in long-duration missions.

About the National Stem Cell Foundation

The National Stem Cell Foundation is a non-profit organization that funds adult stem cell and regenerative medicine research, underwrites a professional development program for middle school science teachers inspiring the next generation of STEM pioneers nationwide, and covers copays and deductibles for children participating in clinical trials for rare diseases when those out-of-pocket costs are beyond a family's means. For more information, visit www.nationalstemcellfoundation.org.

Media Contact

Ceci Conway, National Stem Cell Foundation, 1 5025947196, [email protected], www.nationalstemcellfoundation.org

SOURCE National Stem Cell Foundation

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.